🧬 GEFFON Gefitinib 250 mg Tablets 🔹 Introduction Gefitinib 250 mg tablets (brand: GEFFON) are targeted anti-cancer medicines used mainly for treating non-small cell lung cancer (NSCLC). These tablets belong to a class called tyrosine kinase inhibitors (TKIs) and are widely used in patients with EGFR mutations. 🔬 Composition & Content Active Ingredient: Gefitinib 250 mg Drug Class: EGFR Tyrosine Kinase Inhibitor Form: Oral tablet How it works: Gefitinib blocks the epidermal growth factor receptor (EGFR), which helps stop cancer cell growth and division. 💊 Uses & Treatments GEFFON Gefitinib 250 mg is primarily used for: ✔️ Non-Small Cell Lung Cancer (NSCLC) ✔️ EGFR mutation-positive lung cancer ✔️ Advanced or metastatic lung cancer ✔️ First-line targeted therapy in eligible patients 👉 Especially effective in tumors with: Exon 19 deletions Exon 21 (L858R) mutations 📌 Dosage & How to Use Standard Dose: 250 mg once daily Take with or without food Swallow whole with water Continue treatment as advised by oncologist ⚠️ Dose adjustments may be needed based on: Side effects Liver function Patient tolerance ⚙️ How It Works (Mechanism) Targets EGFR protein on cancer cells Blocks tumor signaling pathways Slows or stops cancer progression 👉 This is precision medicine, meaning it works best in genetically selected patients. ✅ Advantages ✔️ Oral therapy (no hospitalization needed) ✔️ Targeted action (less damage to healthy cells) ✔️ Better tolerability than chemotherapy ✔️ Improves progression-free survival in EGFR-positive patients ✔️ Convenient once-daily dosing ⚠️ Possible Side Effects Common side effects include: Skin rash Diarrhea Nausea & vomiting Loss of appetite Weakness 👉 Serious (rare): Lung inflammation (interstitial lung disease) Liver toxicity 🧊 Storage Conditions Store below 25–30°C Keep away from moisture & sunlight Store in original packaging Keep out of reach of children 🇮🇳 Alternative Indian Brands (Gefitinib 250 mg) Here are widely available same-composition alternatives: Geftinat 250 mg Tablet (Natco Pharma) Gefticip 250 mg Tablet (Cipla Ltd) Geftibenz 250 Tablet Geftisym 250 Tablet Gefshil 250 Tablet K-Gef 250 mg Tablet 👉 All contain Gefitinib 250 mg and are used for the same indication. 🌍 Global Demand & Export Relevance Gefitinib is highly demanded in: Saudi Arabia (Riyadh, Jeddah, Mecca, Medina, Dammam) USA, UK, UAE, Europe Southeast Asia & Africa 👉 Due to affordability and availability, Indian generics are preferred worldwide. 📦 Advantages for Export (GlobMedIndia) WHO-GMP compliant manufacturing Cost-effective generic versions Bulk supply capability Fast global shipping Reliable oncology portfolio 💊 Order GEFFON Gefitinib 250 mg Tablets Online – Trusted Anti-Cancer Medicine Supplier Buy GEFFON Gefitinib 250 mg Tablets at the best price from GlobMedIndia – a leading exporter of high-quality oncology medicines from India. Gefitinib is a targeted therapy used for EGFR-positive non-small cell lung cancer (NSCLC), offering effective and convenient oral treatment. 🌍 We deliver globally: Saudi Arabia (Riyadh, Jeddah, Mecca, Medina, Dammam), UAE, USA, UK, Europe, Australia, Africa, Southeast Asia, and more. ✅ 100% Genuine Medicines ✅ WHO-GMP Certified Suppliers ✅ Fast & Safe International Delivery ✅ Competitive Wholesale Prices 💡 Also available alternatives: Geftinat, Gefticip, Gefshil, Geftisym, K-Gef 📦 Order now from GlobMedIndia – Your Trusted Global Medicine Exporter #Gefitinib #LungCancerTreatment #AntiCancerMedicines #OncologyDrugs #GlobMedIndia #TargetedTherapy #NSCLC #CancerCare #PharmaExporter #BuyMedicinesOnline #SaudiArabia #UAE #USA #UK #Europe #IndiaPharmacy 🧾 Conclusion GEFFON Gefitinib 250 mg Tablets is a highly effective targeted cancer therapy for EGFR-positive lung cancer patients. With strong clinical benefits, oral convenience, and multiple affordable Indian alternatives, it remains a preferred global oncology drug—especially in export markets. https://globmedindia.com Contact Details : Email Id : info@globmedindia.com Phone No. : 9730316395 Whatsapp No. : 9730316395